<Page>
-------------------------------
OMB Approval
-------------------------------
OMB Number: 323-0167
Expires: October 31, 2004
Estimated average burden
Hours per response...1.50
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-27602
------------------------------
NCS HealthCare, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as specified in its charter)
3201 Enterprise Parkway, Suite 220, Beachwood, Ohio 44122, (216) 378-6800
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
Class A common stock, par value $0.01 per share
- --------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- --------------------------------------------------------------------------------
(Title of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [x] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [x]
Approximate number of holders of record as of the certification or notice date:
One
- ------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934,
NCS HealthCare, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
DATE: January 16, 2003 BY: /s/ Joel F. Gemunder
------------------------ ------------------------------
Name: Joel F. Gemunder
Title: President and Chief Executive Officer
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
Persons who respond to the collection of information
contained in this form are not required to respond
unless the form displays
SEC 2069 (01-02) a currently valid OMB control number.